Skip to content

Valhi VHI Chemicals — Goodwill

Other segment segments

Component Products
$27.1M0.0%

Similar metrics at other companies

Innospec logo
IOSPPerformance Chemicals — Goodwill
$144.5M+11.1%
Koppers Holdings logo
KOPPerformance Chemicals — Goodwill
$172.9M+0.5%
Ingevity logo
NGVTPerformance Chemicals — Goodwill
$0
Cabot Corporation logo
CBTPerformance Chemicals — Goodwill
$86M+4.9%
Innospec logo
IOSPPerformance Chemicals — Goodwill Gross
$144.5M+11.1%
Innospec logo
IOSPPerformance Chemicals — Goodwill Acquired
$0

Other financials

Income statement

See full
Revenue$560.1M+4.0%
Gross profit$103.0M-15.9%
Net income$2.0M-88.2%
EPS (diluted)$0.07-88.1%

Balance sheet

See full
Cash & equivalents$193.7M-0.4%
Total debt$629.3M+2.9%
Total equity$1.0B-3.5%
Total assets$2.6B-5.3%

Cash flow

See full
Operating cash flow-$46.1M+70.4%
CapEx$10.6M-17.2%
Free cash flow-$56.7M+66.4%

Valuation

See full
Market cap$375.29M-15.1%
Enterprise value$810.89M-5.6%
P/S0.2×0.0×

Profitability

See full
Gross margin13.1%-8.7pp
Net margin-3.5%-9.0pp
FCF margin12.9%

Returns & leverage

See full
Return on equity-6.9%-18.7pp
Debt / equity0.6×0.0×
Current ratio3.2×+0.6×

Where this comes from

Reported directly by Valhi in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Valhi’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Valhi's chemicals — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Valhi's chemicals — goodwill?
Valhi (VHI) reported chemicals — goodwill of $355.2M in Q4 2025.
How has Valhi's chemicals — goodwill changed year-over-year?
Valhi's chemicals — goodwill decreased by 0.0% year-over-year, from $355.2M to $355.2M.
What does chemicals — goodwill mean?
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations within the chemicals segment. This intangible asset reflects the premium paid for synergies, brand value, and market position. It is subject to periodic impairment testing, which can impact the segment's reported financial position.